Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Pfizer Q3 Adj. EPS $0.87 Beats $0.63 Estimate, Sales $16.654B Beat $16.592B Estimate

Author: Benzinga Newsdesk | November 04, 2025 06:45am
Pfizer (NYSE:PFE) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.63 by 38.31 percent. This is a 17.92 percent decrease over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $16.654 billion which beat the analyst consensus estimate of $16.592 billion by 0.37 percent. This is a 5.92 percent decrease over sales of $17.702 billion the same period last year.

Posted In: PFE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist